Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
Title:
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
Author:
Smit, Egbert F Felip, Enriqueta Uprety, Dipesh Nagasaka, Misako Nakagawa, Kazuhiko Paz-Ares Rodríguez, Luis Pacheco, Jose M Li, Bob T Planchard, David Baik, Christina Goto, Yasushi Murakami, Haruyasu Saltos, Andreas Pereira, Kaline Taguchi, Ayumi Cheng, Yingkai Yan, Qi Feng, Wenqin Tsuchihashi, Zenta Jänne, Pasi A